Role of MBL, MASP2 and NOD2 Polymorphisms in Patients with Inflammatory Bowel Disease

A. Weimann, A. Lun, C. Buening, H. H. Schmidt, H. Lochs, Falko Sniehotta, R. Gessner, E. Koettgen

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	145-145
Number of pages	0
Journal	Clinical Chemistry and Laboratory Medicine
Volume	42
Issue number	10
Publication status	Published - 2004

Cite this

@article{66c28323f4954acc9e17a73a2e221de1,

title = "Role of MBL, MASP2 and NOD2 Polymorphisms in Patients with Inflammatory Bowel Disease",

author = "A. Weimann and A. Lun and C. Buening and Schmidt, {H. H.} and H. Lochs and Falko Sniehotta and R. Gessner and E. Koettgen",

year = "2004",

language = "English",

volume = "42",

pages = "145--145",

journal = "Clinical Chemistry and Laboratory Medicine",

issn = "1434-6621",

publisher = "Walter de Gruyter GmbH",

number = "10",

}

TY - JOUR

T1 - Role of MBL, MASP2 and NOD2 Polymorphisms in Patients with Inflammatory Bowel Disease

AU - Weimann, A.

AU - Lun, A.

AU - Buening, C.

AU - Schmidt, H. H.

AU - Lochs, H.

AU - Sniehotta, Falko

AU - Gessner, R.

AU - Koettgen, E.

PY - 2004

Y1 - 2004

M3 - Article

SN - 1434-6621

VL - 42

SP - 145

EP - 145

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

IS - 10

ER -